Glycolipid transfer proteins (GLTP) Inhibitors belong to a distinctive chemical class characterized by their capacity to modulate the activity of glycolipid transfer proteins. Glycolipids, which consist of a carbohydrate moiety linked to a lipid, play pivotal roles in cellular membrane structure, signaling, and recognition. GLTPs, in turn, are responsible for the intracellular transport of glycolipids between membranes, facilitating their incorporation into various cellular compartments. Inhibition of GLTPs represents a nuanced approach to influencing glycolipid dynamics within cells. The chemical entities classified as GLTP inhibitors typically exert their effects by interfering with the binding or transfer process mediated by GLTPs.
GLTP inhibitors involves structural elements that interact with specific regions of the GLTP molecule, disrupting its normal functioning. These inhibitors may function through competitive binding to the glycolipid binding site of GLTP or by altering the conformation of the protein, hindering its ability to facilitate glycolipid transfer. The development of GLTP inhibitors is grounded in a profound understanding of the intricate molecular interactions governing glycolipid metabolism. As researchers delve deeper into the structural and functional aspects of GLTPs, the design and optimization of inhibitors continue to evolve, offering potential insights into novel strategies for manipulating glycolipid-related cellular processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein can inhibit protein tyrosine kinases, potentially altering GLTP function by affecting its phosphorylation state. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin can modulate kinase activity, which may influence GLTP activity indirectly through kinase-dependent pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin can inhibit PI3K, possibly affecting GLTP activity due to PI3K's role in cellular trafficking processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 can inhibit MEK, which may alter GLTP's function or expression through the MAPK signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 can inhibit PI3K, potentially affecting the intracellular localization and function of GLTP. | ||||||
Triacsin C Solution in DMSO | 76896-80-5 | sc-200574 sc-200574A | 100 µg 1 mg | $187.00 $843.00 | 14 | |
Triacsin C can inhibit acyl-CoA synthetase, possibly affecting lipid metabolism and indirectly GLTP's lipid transfer. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 can inhibit neutral sphingomyelinase, potentially affecting sphingolipid levels and thus GLTP's substrate pool. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
D609 can inhibit phosphatidylcholine-specific phospholipase C, possibly influencing cellular lipid composition for GLTP. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A can inhibit Ras farnesyltransferase, potentially affecting GLTP's associated signaling pathways. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A can disrupt the Golgi apparatus, potentially affecting the glycolipid transport and function of GLTP. | ||||||